Abstract
Higher calling. After 2 decades spent chasing both promising ideas and dead ends for big pharma, virologist Emilio Emini is shifting gears to focus all his energies on one goal: finding an AIDS vaccine that works. Last week, the 50-year-old Emini bid adieu to Merck's vaccines and biologics division, which he's headed since 1997, to join the International AIDS Vaccine Initiative (IAVI).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
